ArticleJournal of public health research2025
Vaccination coverage against HPV in a national representative sample of schoolgirls aged 12-18 years in Greece and core knowledge factors in parents' decision to vaccinate their daughters.
Article in Journal of public health research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: HPV vaccination coverage is important to prevent cervical cancer and other HPV-related diseases. This study estimated the vaccination coverage rate among adolescent schoolgirls aged 12-18 in Greece and identified factors affecting parental vaccination decisions. Design and Methods: A cross-sectional study was conducted from September 2021 to March 2022. A nationwide representative sample of 3205 parents/guardians of schoolgirls from 48 schools was selected through a probabilistic multistage sampling. Besides descriptive statistics, estimation, exploration and inferential methods were used, including 95% CI to estimate the vaccine rate, exploratory factor analysis to emerge the factors of HPV knowledge and multiple logistic regression analysis to identify the crucial parameters associated with vaccination, after adjusting for mutual confounding. Results: About 62.5% [95% CI: 61.1-63.9] of the girls were fully vaccinated. Mother's HPV vaccination (OR [95% CI] = 2.90 [1.77, 4.73]), parental education level (OR [95% CI] = 2.50 [1.65, 3.79]), child's attendance at the Upper secondary school (OR [95% CI] = 2.36 [1.83, 3.03]) and the level of HPV vaccine knowledge (OR [95% CI] = 1.59 [1.37, 1.84]) influenced parents' decision to vaccinate their daughters. Conclusions: A significant increase in HPV vaccination coverage was recorded in Greece, compared to previous estimations. The identified determinants of parents' vaccination decisions, especially HPV vaccine knowledge, can feed into targeted public health policies, to achieve the WHO's goal to vaccinate 90% of adolescent girls by 2030. Policies may include the implementation of school-based awareness programmes for students and parents, state incentives for parents and expert recommendations for vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.